Navellier & Associates’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-25,916	Closed	-$2.07M	–	311
2022 Q2	$2.07M	Sell	25,916 -699	-3%	-$66.2K	0.44%	81
2022 Q1	$2.8M	Sell	26,615 -10,391	-28%	-$1.01M	0.48%	77
2021 Q4	$3.99M	Buy	37,006 +749	+2%	+$81.7K	0.58%	62
2021 Q3	$3.97M	Buy	36,257 +988	+3%	+$103K	0.6%	58
2021 Q2	$3.3M	Buy	35,269 +892	+3%	+$82.1K	0.5%	71
2021 Q1	$3.16M	Sell	34,377 -437	-1%	-$36.9K	0.57%	62
2020 Q4	$2.55M	Buy	34,814 +4,954	+17%	+$368K	0.46%	76
2020 Q3	$2.32M	Buy	+29,860	New	+$2.05M	0.51%	70
2015 Q4	–	Sell	-23,050	Closed	-$457K	–	328
2015 Q3	$457K	Buy	23,050 +10,550	+84%	+$333K	0.05%	171
2015 Q2	$434K	Buy	12,500 +500	+4%	+$15.3K	0.04%	227
2015 Q1	$312K	Hold	12,000	–	–	0.03%	275
2014 Q4	$155K	Buy	+12,000	New	+$150K	0.01%	318